International Biotechnology Trust’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

International Biotechnology Trust’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-1,505,809	Closed	-$2.73M	–	66
2018 Q1	$2.73M	Buy	1,505,809 +5	+0%	+$11	1.06%	26
2017 Q4	$3.36M	Buy	1,505,804 +533,882	+55%	+$1.33M	1.18%	26
2017 Q3	$2.8M	Buy	971,922 +199,922	+26%	+$682K	1.09%	30
2017 Q2	$3.43M	Buy	772,000 +460,000	+147%	+$1.9M	1.3%	25
2017 Q1	$1.45M	Hold	312,000	–	–	0.56%	37
2016 Q4	$1.9M	Buy	+312,000	New	+$1.63M	0.86%	26

Other funds holding SGYP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hikari Power Tokyo, Japan $855M AUM 14.24% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

International Biotechnology Trust's SGYP Position: Q2 2018 in Review

International Biotechnology Trust sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q2 2018, closing a stake of 1,505,809 shares — an estimated $2.73M sold.

International Biotechnology Trust first reported a position in SGYP in Q4 2016 and held it in 6 quarters. The position peaked at $3.43M in Q2 2017. 136 funds tracked by Wall St. Rank hold SGYP as of Q2 2018.

International Biotechnology Trust reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q2 2018 after selling out during the quarter.
International Biotechnology Trust sold 1,505,809 Synergy Pharmaceuticals, Inc Common Stock shares in Q2 2018, an estimated $2.73M.
International Biotechnology Trust first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2016 and held it in 6 quarters.
International Biotechnology Trust's Synergy Pharmaceuticals, Inc Common Stock position peaked at $3.43M in Q2 2017.
136 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q2 2018.

Based on International Biotechnology Trust's 13F filing for Q2 2018, filed 13 Aug 2018.